RU2019141646A3 - - Google Patents

Download PDF

Info

Publication number
RU2019141646A3
RU2019141646A3 RU2019141646A RU2019141646A RU2019141646A3 RU 2019141646 A3 RU2019141646 A3 RU 2019141646A3 RU 2019141646 A RU2019141646 A RU 2019141646A RU 2019141646 A RU2019141646 A RU 2019141646A RU 2019141646 A3 RU2019141646 A3 RU 2019141646A3
Authority
RU
Russia
Application number
RU2019141646A
Other languages
Russian (ru)
Other versions
RU2019141646A (ru
RU2766160C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2019141646A publication Critical patent/RU2019141646A/ru
Publication of RU2019141646A3 publication Critical patent/RU2019141646A3/ru
Application granted granted Critical
Publication of RU2766160C2 publication Critical patent/RU2766160C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2019141646A 2017-05-17 2018-05-17 Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента RU2766160C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2017-0061250 2017-05-17
KR20170061250 2017-05-17
PCT/KR2018/005673 WO2018225961A1 (ko) 2017-05-17 2018-05-17 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물

Publications (3)

Publication Number Publication Date
RU2019141646A RU2019141646A (ru) 2021-06-17
RU2019141646A3 true RU2019141646A3 (cg-RX-API-DMAC7.html) 2021-07-28
RU2766160C2 RU2766160C2 (ru) 2022-02-08

Family

ID=64566301

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019141646A RU2766160C2 (ru) 2017-05-17 2018-05-17 Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента

Country Status (13)

Country Link
US (1) US12037415B2 (cg-RX-API-DMAC7.html)
EP (1) EP3643723B1 (cg-RX-API-DMAC7.html)
JP (2) JP7680824B2 (cg-RX-API-DMAC7.html)
KR (2) KR102287226B1 (cg-RX-API-DMAC7.html)
CN (1) CN110945012A (cg-RX-API-DMAC7.html)
AU (1) AU2018281617B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019024040A2 (cg-RX-API-DMAC7.html)
CA (1) CA3063842A1 (cg-RX-API-DMAC7.html)
ES (1) ES2982308T3 (cg-RX-API-DMAC7.html)
MX (1) MX2019013799A (cg-RX-API-DMAC7.html)
RU (1) RU2766160C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201912110YA (cg-RX-API-DMAC7.html)
WO (1) WO2018225961A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12037415B2 (en) * 2017-05-17 2024-07-16 Yuyu Pharma, Inc. Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient
TWI865470B (zh) * 2018-11-14 2024-12-11 南韓商柳柳製藥股份有限公司 治療眼睛疾病之肽及醫藥組合物
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
BR112021023477A2 (pt) * 2019-05-21 2022-02-15 Eyebio Korea Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório
KR20210104460A (ko) * 2020-02-17 2021-08-25 주식회사 아이바이오코리아 고체상 합성법을 이용한 펩타이드의 제조 방법
WO2021191689A2 (en) * 2020-03-05 2021-09-30 Yuyu Pharma, Inc. Treatment of inflammatory diseases with peptides and pharmaceutical compositions
MX2024006997A (es) * 2021-12-13 2024-06-19 Eyebiokorea Inc Composicion para el tratamiento de la degeneracion macular que comprende un nuevo peptido.
KR102593936B1 (ko) * 2021-12-13 2023-10-27 주식회사 아이바이오코리아 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물
KR102587729B1 (ko) * 2023-02-27 2023-10-12 주식회사 아이바이오코리아 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물
KR102673860B1 (ko) * 2023-08-10 2024-06-12 (주)케어젠 안구 건조증의 개선 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
WO2007117444A2 (en) * 2006-03-31 2007-10-18 Yinghe Hu Protein detection by aptamers
WO2009039854A2 (en) 2007-09-27 2009-04-02 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
US20090131303A1 (en) * 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye
JP4490498B2 (ja) * 2008-09-30 2010-06-23 新田ゼラチン株式会社 疾病抑制剤
UA113627C2 (xx) 2011-05-27 2017-02-27 Кристалічна форма циклоспорину a, фармацевтична композиція та спосіб лікування
WO2013079213A1 (en) 2011-11-30 2013-06-06 Xigen Inflammation Ltd. Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome
KR101438744B1 (ko) 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
KR101948156B1 (ko) 2013-12-10 2019-02-14 인제대학교 산학협력단 알칼리 화상을 이용한 각막 혼탁증 동물모델 및 각막 혼탁증 예방 또는 치료용 약학조성물
KR101555296B1 (ko) 2013-12-10 2015-09-23 인제대학교 산학협력단 연골세포 유래 세포외 기질을 유효성분으로 함유하는 건성안 예방 또는 치료용 약학조성물
KR101721059B1 (ko) 2014-12-26 2017-03-30 주식회사 아이바이오코리아 안구 표면 질환 예방 또는 치료용 약학조성물
KR101690539B1 (ko) 2015-07-30 2016-12-29 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
AU2016373364B2 (en) 2015-12-14 2019-07-11 Tsung-Chuan Ho Short synthetic peptide and uses thereof
KR101798183B1 (ko) * 2016-04-08 2017-11-15 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
ES2822289T3 (es) 2016-04-08 2021-04-30 Eyebio Korea Péptido a base de colágeno tipo II alfa-1 para su uso en el tratamiento de la degeneración macular
KR101795653B1 (ko) * 2016-05-19 2017-11-09 인제대학교 산학협력단 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
KR20180074928A (ko) 2016-12-26 2018-07-04 주식회사 아이바이오코리아 건성안 예방 또는 치료용 동물 의약품 조성물
US12037415B2 (en) 2017-05-17 2024-07-16 Yuyu Pharma, Inc. Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient
TWI865470B (zh) * 2018-11-14 2024-12-11 南韓商柳柳製藥股份有限公司 治療眼睛疾病之肽及醫藥組合物
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
WO2021191689A2 (en) * 2020-03-05 2021-09-30 Yuyu Pharma, Inc. Treatment of inflammatory diseases with peptides and pharmaceutical compositions

Also Published As

Publication number Publication date
JP7680824B2 (ja) 2025-05-21
JP2023098936A (ja) 2023-07-11
BR112019024040A2 (pt) 2020-09-24
MX2019013799A (es) 2020-08-13
AU2018281617B2 (en) 2022-06-30
KR102498428B1 (ko) 2023-02-20
KR20210097670A (ko) 2021-08-09
EP3643723C0 (en) 2024-05-15
RU2019141646A (ru) 2021-06-17
JP7775250B2 (ja) 2025-11-25
EP3643723A1 (en) 2020-04-29
CN110945012A (zh) 2020-03-31
WO2018225961A1 (ko) 2018-12-13
US12037415B2 (en) 2024-07-16
EP3643723B1 (en) 2024-05-15
CA3063842A1 (en) 2019-12-09
AU2018281617A1 (en) 2019-12-05
KR102287226B1 (ko) 2021-08-11
EP3643723A4 (en) 2021-03-31
SG11201912110YA (en) 2020-01-30
US20210024577A1 (en) 2021-01-28
RU2766160C2 (ru) 2022-02-08
ES2982308T3 (es) 2024-10-15
KR20180126406A (ko) 2018-11-27
JP2020520372A (ja) 2020-07-09

Similar Documents

Publication Publication Date Title
BR122021000189A2 (cg-RX-API-DMAC7.html)
BR112019008823A2 (cg-RX-API-DMAC7.html)
BR112020006084A8 (cg-RX-API-DMAC7.html)
BR112019025875B1 (pt) Sistema de cilindro com estrutura de ocupação de movimento relativo
BR112020011860B1 (pt) Dispositivo cirúrgico para cortar uma lente dentro de um saco capsular de um olho
BR112020006283B1 (pt) Placa refinadora, e, refinador para tratamento mecânico de material orgânico/celulósico
BR112020008714B1 (pt) Uso de medicamentos serotoninérgicos para tratar trombocitopenia induzida por vírus
BR112020006992B1 (pt) Dispositivo de recolhimento e método para o recolhimento de uma embarcação
BR112019023976B1 (pt) Sistema e método para comunicar dados de saúde em um ambiente de cuidados de saúde
BR112020003314B1 (pt) Sistema terapêutico transdérmico para administração transdérmica de um agente ativo, seu método de fabricação, usos de emulsificante, e método para estabilizar uma mistura de revestimento bifásica
BR112020003112B1 (pt) Método de garantir a viabilidade de uma máquina para uma tarefa agendada
BR112020002577B1 (pt) Método de melhoria de rendimento de centrifugação dupla para purificação de óleo nutritivo
BR112020003569B1 (pt) Método e disposição para transmissão de dados comutados por pacote entre dispositivos de emissão e recepção marítimos para uma embarcação marítima e dispositivos de emissão e recepção terrestres por interfaces aéreas
BR112019016885B1 (pt) Remodelagem de imagem integrada e codificação de vídeo
BR112019027876B1 (pt) Método de codificação para uma comunicação sem fio, codificador, método de decodificação, decodificador, aparelho de comunicação, meio de armazenagem legível por computador, e sistema de comunicações
BR112020001354B1 (pt) Método, em uma primeira estação base, para suportar posicionamento de um dispositivo móvel e primeira estação base para suportar posicionamento de um dispositivo móvel
BR112019026818B1 (pt) Método de codificação, método de decodificação, aparelho, aparelho de comunicações, terminal, estação base e mídia legível por computador
BR102018011961B1 (pt) Sistemas, métodos e meio não transitório legível por computador para analisar cores a partir de uma plataforma de mídia social
BR112019026880B1 (pt) Método de comunicação, método para receber dados, e, dispositivo
BR112019024244B1 (pt) Processos de fermentação de metano de alta produtividade
BR112019023944B1 (pt) Combinação farmacêutica para o tratamento de um câncer
BR112019021396B1 (pt) Processo para fabricação de pululano
BR102018003507B1 (pt) Sistema de isolamento de tensão de tambor de guincho
BR112019016182B1 (pt) Método para diagnosticar risco de revisão relacionado a implante
BR112019014127B1 (pt) Composição farmacêutica para tratamento de tumores